Company intelligence / Profile preview

Navbit

Sydney, New South Wales, Australianavbit.com ↗

Ownership: Private
Development stage: Commercial

Overview

Navbit has developed and commercialized the Navbit Sprint, a compact, single-use navigation device for accurate acetabular cup placement during hip replacement surgery. The device has regulatory clearances in Australia (TGA), Europe (CE Mark), and the US (FDA). Clinical data show high accuracy with average errors of 2.13° in inclination and 2.36° in anteversion[6][7]. The product addresses a major cause of revision surgeries—misalignment—and aims to reduce post-operative dislocation rates.

Therapeutic areas: Rheumatology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Smith+Nephew (exclusive distribution for Japan, Australia, expanded globally)Johnson & Johnson Medical (distribution partnership for Australia)

Beyond the preview

Go deeper on Navbit.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Navbit.

Explore the full profile